19-53068927-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001322131.2(ZNF160):āc.1607C>Gā(p.Pro536Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P536T) has been classified as Uncertain significance.
Frequency
Consequence
NM_001322131.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF160 | NM_001322131.2 | c.1607C>G | p.Pro536Arg | missense_variant | 6/6 | ENST00000683776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF160 | ENST00000683776.1 | c.1607C>G | p.Pro536Arg | missense_variant | 6/6 | NM_001322131.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151934Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251388Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135866
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.0000426 AC XY: 31AN XY: 727234
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151934Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74202
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.1607C>G (p.P536R) alteration is located in exon 7 (coding exon 4) of the ZNF160 gene. This alteration results from a C to G substitution at nucleotide position 1607, causing the proline (P) at amino acid position 536 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at